FR940628-0-00007 FR940628-0-00005 21 CFR Parts 510 and 522 Animal Drugs, Feeds, and Related Products; Change of Sponsor AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor name and address for a new animal drug application (NADA) from Med-Chem Products, Inc. to Anika Research, Inc. EFFECTIVE DATE: June 28, 1994. FOR FURTHER INFORMATION CONTACT: Benjamin A. Puyot, Center for Veterinary Medicine (HFV&hyph;130), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1646. SUPPLEMENTARY INFORMATION: Med-Chem Products, Inc., Woburn, MA 01801, has informed FDA that it has transferred ownership of, and all rights and interests in, approved NADA 122&hyph;578 for Hyaluronate sodium injection to Anika Research, Inc., 160 New Boston St., Woburn, MA 01801. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) by removing Med-Chem Products, Inc., because the firm is no longer the sponsor of any approved NADA's, and by alphabetically adding a new listing for Anika Research, Inc. List of Subjects 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. 21 CFR Part 522 Animal drugs. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 522 are amended as follows: PART 510_NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority: Secs. 201, 301, 501, 502, 503, 512, 701, 721 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e). 2. Section 510.600 is amended in the table in paragraph (c)(1) by removing the entry for ``Med-Chem Products, Inc.'' and by alphabetically adding a new entry for ``Anika Research, Inc.,'' and in the table in paragraph (c)(2) by removing the entry for ``053276'' and by numerically adding a new entry for ``060865'' to read as follows: §510.600 Names, addresses, and drug labeler codes of sponsors of approved applications. * * * * * (c) *␣*␣* (1) *␣*␣* 1Firm name and address 1Drug labeler code ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ Anika Research, Inc., 160 New Boston St., Woburn, MA 01801 060865 ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ (2) *␣*␣* 1Drug labeler code 1Firm name and address ␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣␣*␣␣ 060865 Anika Research, Inc., 160 New Boston St., Woburn, MA 01801 PART 522_IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS 3. The authority citation for 21 CFR part 522 continues to read as follows: Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). §522.1145 [Amended] 4. Section 522.1145 Hyaluronate sodium injection is amended in paragraph (a)(2) by removing the number ``053276'' and adding in its place ``060865''. Dated: June 17, 1994. Robert C. Livingston, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 94&hyph;15604 Filed 6&hyph;27&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
